Neogen Chemicals Q3FY26: Revenue ₹215.60 Cr, Profit ₹8.77 Cr Standalone
Neogen Chemicals reported standalone Q3FY26 revenue of ₹215.60 Cr and profit of ₹8.77 Cr. Consolidated Q3FY26 profit was ₹3.69 Cr. The company continues to process insurance claims related to the March 2025 fire incident at its Dahej plant.
The results are for a single quarter and the ongoing insurance claim resolution for a significant fire incident could impact future financial performance. The market will be looking for updates on claim settlement and its impact on the company's financials.
The financial results show a mixed performance with a slight decrease in standalone profit compared to the previous year's quarter, while consolidated profit also saw a decline. The ongoing insurance claim process for the fire incident adds a layer of uncertainty.
Neogen Chemicals Limited announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. For the standalone results, the company reported total income of ₹219.86 crore and a profit after tax of ₹8.77 crore for the quarter ended December 31, 2025. The revenue from operations stood at ₹215.60 crore.
For the nine-month period ended December 31, 2025, standalone total income was ₹618.81 crore, with a profit after tax of ₹32.30 crore. The consolidated total income for the quarter was ₹222.11 crore, and the profit after tax was ₹3.69 crore. For the nine-month period, consolidated total income was ₹620.55 crore, and profit after tax was ₹17.33 crore.
The company also provided an update on the fire incident at its Dahej SEZ plant on March 05, 2025. The assessment of the loss claim submitted to the insurance company is in process, with ₹50.00 crore received as an on-account payment during the quarter ended June 30, 2025, and ₹30.00 crore during the quarter ended September 30, 2025. An additional ₹3.48 crore was realized from the sale of scrap.
The company's Board of Directors approved these results on February 11, 2026.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.